Medical Device JCAs Launch and Novel Mechanism Approvals

Episode 25 — 08 June 2026 Medical device Joint Clinical Assessments begin in June 2026 as the EU HTA Regulation expands beyond oncology medicines. FDA approves first-in-class aldosterone synthase inhibitor baxdrostat while ISPOR signals a shift toward evidence judgment over generation. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast

Episode metadata supplied by the publisher feed · Published Jun 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Medical Device JCAs Launch and Novel Mechanism Approvals

0:00 5:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Carl Haakon's Podcast?

This episode is 5 minutes long.

When was this Carl Haakon's Podcast episode published?

This episode was published on June 8, 2026.

Can I download this Carl Haakon's Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!